Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients

Chemotherapy

Volumn 52, Issue 6, 2006, Pages 316-320

  Ramazanzadeh, Rashid ^a,b,c,d   Farnia, Parissa ^a   Amirmozafari, Nour ^b   Ghazi, Farideh ^b   Ghadertotonchi, Zeinab ^a   Kamran, Jaber ^a   Mohammadi, Frouzan ^a   Mirsaedi, Mehdi ^a   Masjedi, Mohammadreza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF KURDISTAN   (Iran)

^d KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drugs; Resistance; Spoligotyping; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

AFGHANISTAN; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM SPOLIGOTYPING; CELL ISOLATION; CONTROLLED STUDY; EVOLUTIONARY RATE; GEOGRAPHIC DISTRIBUTION; INFECTION RISK; IRAN; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ADULT; AFGHANISTAN; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ETHAMBUTOL; GENOTYPE; HUMANS; IRAN; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; RISK FACTORS; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33750268806     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095971     Document Type: Article

References (9)

1. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA: Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002;40:1930-1937.
2. Soini H, Pan X, Amin A, Graviss EA, Siddiqui A, Musser JM: Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. J Clin Microbiol 2000;38:669-676.
3. Sola C, Filliol I, Gutierrez MC, Mokrousov I, Vincent V, Rastogi N: Spoligotyping database of Mycobacterium tuberculosis: biographic distribution of shared types and phylogenetin perspectives. Emerg Infect Dis 2001;7:390-396.
4. Mansoori SD, Arami S, Mirabolhasani Z, Farnia P, Velayati A: The pattern of drug resistance among newly diagnosed and old cases of pulmonary tuberculosis in NRITLD. Arch Iranian Med 2003;6:255-260.
5. Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D: Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002;8:843-849.
6. Van Soolingen D, Qian L, de Haas PEW, Douglas JT, Traore H, Portaels F, Enkhasaikan D, Nymadawa P, Van Embden JDA: Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995;33:3234-3238.
7. Schaaf HS, Shean K, Donald PR: Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child 2003;88:1106-1111.
8. Youngchaiyud P, Iseman MD: Update treatment of multidrug-resistant tuberculosis, Introduction, discussion and summary. Chemotherapy. 1999;45(suppl 2):1-2, 41-45.
9. Iseman MD: Management of multidrug-resistant tuberculosis.Chemotherapy. 1999;45 (suppl 2):3-11.